Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2023 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech and Graf Acquisition Corp. IV Announce the Nomination of Two Independent Directors for the Board of Directors of the Post-Business Combination Public Company

SANTA ANA, Calif. and THE WOODLANDS, Texas, Aug. 09, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and...
July 17, 2023 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference

SANTA ANA, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (NKGen), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
July 10, 2023 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Announces Poster Presentation at the 2023 Alzheimer’s Association International Conference

SANTA ANA, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
July 06, 2023 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech Inc. and Graf Acquisition Corp. IV to Co-Host Investor Event

SANTA ANA, Calif. and THE WOODLANDS, Texas, July 06, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of...
June 13, 2023 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech to Present at the 2nd International Alzheimer’s Disease & Dementia Conference 2023

SANTA ANA, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
June 05, 2023 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech Announces SNK01 Preclinical and Phase I/IIa Clinical Data Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

SANTA ANA, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (NKGen), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
May 25, 2023 13:05 ET | Source: NKGen Biotech, Inc.

NKGen Announces Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

SANTA ANA, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,...
June 21, 2022 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech to Participate in Truist Securities Cell Therapy Symposium

SANTA ANA, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell...
May 26, 2022 17:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech To Present SNK01 Clinical Data at the 2022 ASCO Annual Meeting

SANTA ANA, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech Inc., a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
May 05, 2022 08:00 ET | Source: NKGen Biotech, Inc.

NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting

SANTA ANA, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech Inc., a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...